HIV research yields potential drug target

Humans possess a formidable multi-layered defense system that protects us against viral infections. Better understanding of these defenses and the tricks that viruses use to evade them could open novel avenues for treating viral infections and possibly other diseases. For example, a human protein called SAMHD1 impedes replication of the human immunodeficiency virus (HIV) and other viruses by depleting deoxynucleotides -- building blocks needed for the replication of the viral genome. It has long remained a mystery whether and how this protein is activated in response to infection.
Now researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have discovered that SAMHD1 recognizes a unique molecular pattern in nucleic acids. This pattern, called "phosphorothioation," may act as a signal for action. It's like a sentinel atop a palace wall who sees an invading horde in the distance and calls the troops to battle stations. Understanding the mechanism of SAMHD1 activation could be a step forward in the fight against HIV/AIDS.
Journal of Antivirals & Antiretrovirals is using Editorial Manager System for quality in review process. Editorial Manager is an online manuscript submission, review and tracking systems used by most of the best open access journals. Review processing is performed by the editorial board members of journal or outside experts; at least two independent reviewers approval followed by editor's approval is required for acceptance of any citable manuscript.
Send your manuscript at www.longdom.org/submissions/antivirals-antiretrovirals.html or as an e-mail attachment to our Editorial Office at manuscripts@longdom.org